GlassScriptPhysician profile
Kelly Williams
NPI 1255339701
$3,105.98
in general payments reported to CMS, 2019-2025
40 companies · $777 in 2025
The $777 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $228 · 2021: $355 · 2022: $533 · 2023: $461 · 2024: $395 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $501.08 | 2019-2024 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $340.96 | 2020-2025 | Veozah, Myrbetriq |
| Channel Medsystems, INC. | $250.76 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $226.25 | 2019-2025 | |
| Organon LLC | $211.92 | 2022-2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $185.95 | 2024-2025 | Zurzuvae |
| Boston Scientific Corporation | $156.54 | 2022-2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Mayne Pharma Commercial LLC | $120.24 | 2022-2025 | |
| Millicent US INC | $100.06 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Coopersurgical, INC. | $93.25 | 2019-2024 | Summit Doppler |
| Pfizer INC. | $84.49 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $79.74 | 2023-2025 | Myfembree |
| Myriad Women'S Health, INC. | $76.63 | 2023 | Myrisk |
| Becton, Dickinson and Company | $50.23 | 2021 | |
| Therapeuticsmd, INC. | $45.09 | 2020-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $44.28 | 2023-2025 | Airseal, Vcare |
| Merck Sharp & Dohme LLC | $39.59 | 2019-2022 | |
| Avion Pharmaceuticals | $38.34 | 2021-2022 | |
| Stryker Corporation | $37.58 | 2025 | 1788 |
| Hologic Sales and Service, LLC | $36.59 | 2019-2023 | Coolseal Generator |
| Evofem Biosciences, INC. | $36.00 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $31.10 | 2025 | Exparel |
| Allergan, INC. | $26.68 | 2019 | |
| Supernus Pharmaceuticals, INC. | $25.56 | 2025 | Qelbree |
| Vertex Pharmaceuticals Incorporated | $25.18 | 2024 | |
| Trevena, INC. | $24.06 | 2021 | |
| Linvatec Corporation | $23.03 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.02 | 2020 | |
| Medtronic, INC. | $18.84 | 2022 | |
| Avanos Medical | $16.98 | 2019 | |
| Agile Therapeutics, INC. | $16.77 | 2022 | |
| Duchesnay USA Incorporated | $15.94 | 2019 | |
| Exeltis, USA INC. | $15.85 | 2024 | Slynd |
| Ascend Therapeutics US, LLC | $14.81 | 2021 | |
| Ethicon US, LLC | $14.72 | 2019 | |
| Urovant Sciences INC | $13.16 | 2022 | |
| Aspira Women'S Health INC | $12.95 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.74 | 2022 | |
| Halozyme INC | $12.03 | 2019 | |
| Lupin INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.